Share on LinkedInShare on LinkedIn

ARTICLE · 12 DECEMBER 2018

Glaxo Wellcome v Sandoz: Disclosure In Global Litigation

Glaxo Wellcome v Sandoz: Court gives permission for collateral use of disclosed documents in Belgium

United KingdomLitigation, Mediation & Arbitration

CPR r31.22 provides that a party to whom a document has been disclosed may use the document only for the purpose of the proceedings in which it was disclosed, except where (inter alia) the court gives permission. Permission was sought in this case to use disclosed documents in separate proceedings in Belgium (where disclosure is only available in a very limited form). The two proceedings are part of global litigation between members of the same two groups of companies.

Chief Master Marsh noted that, under English law, "cogent reasons" are needed before a collateral use is allowed, and there has to be a balance between the competing interests of justice. Where the documents are proposed to be used in foreign proceedings, the English court must assume that European courts (absent cogent evidence to the contrary) will ensure that their proceedings are used fairly and therefore that there is no risk of injustice. Here, it was noted that "Use in legal proceedings in

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from